Genentech: Baris Bingol

Por um escritor misterioso
Last updated 29 julho 2024
Genentech: Baris Bingol
I am proud to be part of the scientific team at Genentech that values scientific excellence above all to fuel therapeutic programs for patients in need.
Genentech: Baris Bingol
Baris BINGOL, Genentech, California, Department of Neuroscience
Genentech: Baris Bingol
Genentech: Wendy Sandoval Director & Distinguished Scientist, Microchemistry, Proteomics & lipidomics
Genentech: Baris Bingol
The mitochondrial deubiquitinase USP30 opposes parkin--ediated mitophagy - Document - Gale OneFile: Health and Medicine
Genentech: Baris Bingol
Genentech: Baris Bingol
Genentech: Baris Bingol
Notre Dame High School Report of Philanthropy 2022 by Notre Dame San Jose - Issuu
Genentech: Baris Bingol
Genetic inactivation of RIP1 kinase activity in rats protects against ischemic brain injury. - Abstract - Europe PMC
Genentech: Baris Bingol
Ubiquilin1 promotes antigen-receptor mediated proliferation by eliminating mislocalized mitochondrial proteins
Genentech: Baris Bingol
Global and Regional Changes in Perivascular Space in Idiopathic and Familial Parkinson's Disease - Donahue - 2021 - Movement Disorders - Wiley Online Library
Genentech: Baris Bingol
A Multifaceted Hit-Finding Approach Reveals Novel LC3 Family Ligands
Genentech: Baris Bingol
Ubiquilin1 promotes antigen-receptor mediated proliferation by eliminating mislocalized mitochondrial proteins

© 2014-2024 hellastax.gr. All rights reserved.